Notes to SEFA
Title: 3. Provider Relief Funds
Accounting Policies: The accompanying Schedule of Expenditures of Federal Awards (the Schedule) summarizes the expenditures of Stanford Health Care and its subsidiaries (SHC) under programs of the federal government for the year ended August 31, 2022. The information presented in the Schedule is presented on the accrual basis of accounting and prepared in accordance with the requirements of Title 2 U.S. Code of Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance). Therefore, amounts presented in the Schedule may differ from amounts presented in, or used in the preparation of SHCs consolidated financial statements and it is not intended to and does not present the financial position, results of operations, changes in net assets and cash flows of SHC.
De Minimis Rate Used: N
Rate Explanation: SHC did not elect to use the 10% de minimis cost rate as described in Section 200.414 of Uniform Guidance.
The Schedule includes grant activity related to the Department of Health and Human Services ("HHS") Provider Relief Fund and American Rescue Plan (ARP) Distribution Assistance Listing Number 93.498. As required based on guidance in the 2022 OMB Compliance Supplement, the Schedule includes all Period 2 and Period 3 funds received between July 1, 2020 and June 30, 2021 and expended by December 31, 2021 and June 30, 2022, respectively, as reported to HRSA via the PRF Reporting Portal. The Schedule thus includes $384,307,453 of direct expenditures and $8,552,732 in lost revenue. Given the timing covered by Period 2 and Period 3 funds, certain of these expenses were reflected in SHCs fiscal year 2021 financial statements. Additionally, lost revenue does not represent an expenditure in SHCs financial statements and thus is a reconciling item between the federal expenses in SHCs financial statements and the amount included on the Schedule.
Title: 4.HRSA COVID-19 Testing and Treatment for the Uninsured
Accounting Policies: The accompanying Schedule of Expenditures of Federal Awards (the Schedule) summarizes the expenditures of Stanford Health Care and its subsidiaries (SHC) under programs of the federal government for the year ended August 31, 2022. The information presented in the Schedule is presented on the accrual basis of accounting and prepared in accordance with the requirements of Title 2 U.S. Code of Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance). Therefore, amounts presented in the Schedule may differ from amounts presented in, or used in the preparation of SHCs consolidated financial statements and it is not intended to and does not present the financial position, results of operations, changes in net assets and cash flows of SHC.
De Minimis Rate Used: N
Rate Explanation: SHC did not elect to use the 10% de minimis cost rate as described in Section 200.414 of Uniform Guidance.
SHC conducted COVID-19 testing and/or provided treatment for uninsured individuals with a COVID-19 primary diagnosis on or after February 4, 2020 and as such has requested claims reimbursement under Assistance Listing Number 93.461 Health Resources and Services Administration's ("HRSA") COVID-19 Claims Reimbursement for the Uninsured Program and the COVID-19 Coverage Assistance Fund. SHC has recorded $692,883 on the Schedule of Expenditures of Federal Awards consisting of $1,265,686 reimbursed to date from HRSA on claims with service dates during fiscal year 2022 and a refund of $572,803 in claims with service dates in fiscal year 2021, for patients which were subsequent identified as having retroactive insurance coverage.